The New and Improved Phoenix 8.2!

September 19, 2019
Certara’s latest release of Phoenix 8.2, the industry gold standard in PK/PK software, introduces new capabilities that support our commitment to customer feedback to deliver faster performance, an enhanced user interface, and greater ease of use to our customers. Some of these new key capabilities include:
  • New user-friendly...

How to Perform IVIVC for Delayed Release Drug Formulations

September 25, 2019
In vitro-in vivo correlation (IVIVC) is a predictive mathematical tool that describes the relationship between an in vitro property of a drug dosage form and an in vivo pharmacokinetic response. Drug developers frequently use this approach to waive the requirement to show evidence of in vivo bioavailability or...

US and EU Trends in Clinical Pharmacology for Regulatory Submissions

October 16, 2019
Global drug development programs are becoming increasingly more common as pharmaceutical and biotech companies aim for approval with multiple health authorities either simultaneously or consecutively.  To reduce clinical trial burdens, companies strive to design programs that will facilitate the needs of multiple health authorities. While...

Learn More LinkedIn Twitter Facebook Email